112 related articles for article (PubMed ID: 24671295)
1. Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs.
Nahar S; Bose D; Kumar Panja S; Saha S; Maiti S
Chem Commun (Camb); 2014 May; 50(35):4639-42. PubMed ID: 24671295
[TBL] [Abstract][Full Text] [Related]
2. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
3. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure-activity relationship of the quinazoline ring.
Sirisoma N; Pervin A; Zhang H; Jiang S; Adam Willardsen J; Anderson MB; Mather G; Pleiman CM; Kasibhatla S; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2010 Apr; 20(7):2330-4. PubMed ID: 20188546
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
He J; Wang X; Zhao X; Liang Y; He H; Fu L
Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
7. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
[TBL] [Abstract][Full Text] [Related]
8. The association between anti-tumor potency and structure-activity of protein-kinases inhibitors based on quinazoline molecular skeleton.
Li Y; Xiao J; Zhang Q; Yu W; Liu M; Guo Y; He J; Liu Y
Bioorg Med Chem; 2019 Feb; 27(3):568-577. PubMed ID: 30600149
[TBL] [Abstract][Full Text] [Related]
9. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies on the anticancer activity of 2,4-disubstituted quinazoline derivative.
Su L; Zheng H; Li Z; Qiu J; Chen S; Liu J; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Oct; 1840(10):3123-30. PubMed ID: 25018006
[TBL] [Abstract][Full Text] [Related]
11. Regioselective synthesis of 6-aryl-benzo[h][1,2,4]-triazolo[5,1-b]quinazoline-7,8-diones as potent antitumoral agents.
Wu L; Zhang C; Li W
Bioorg Med Chem Lett; 2013 Sep; 23(17):5002-5. PubMed ID: 23871222
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.
Barbosa ML; Lima LM; Tesch R; Sant'Anna CM; Totzke F; Kubbutat MH; Schächtele C; Laufer SA; Barreiro EJ
Eur J Med Chem; 2014 Jan; 71():1-14. PubMed ID: 24269511
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016).
Hameed A; Al-Rashida M; Uroos M; Ali SA; Arshia ; Ishtiaq M; Khan KM
Expert Opin Ther Pat; 2018 Apr; 28(4):281-297. PubMed ID: 29368977
[TBL] [Abstract][Full Text] [Related]
14. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Zhuo L; Liu J; Wang B; Gao M; Huang A
Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
[TBL] [Abstract][Full Text] [Related]
15. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
Tsang WP; Kwok TT
J Nutr Biochem; 2010 Feb; 21(2):140-6. PubMed ID: 19269153
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
18. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
20. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]